Drug Type Small molecule drug |
Synonyms SVN 015, SVN015 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Major depressive disorder, moderate (MDD) | Preclinical | United Kingdom | 01 Apr 2026 | |
| Stimulant abuse | Preclinical | United Kingdom | 01 Apr 2026 | |
| Cocaine-Related Disorders | Preclinical | United Kingdom | 03 Dec 2025 | |
| Methamphetamine abuse | Preclinical | United Kingdom | 03 Dec 2025 |





